The National Cancer Institute of Milan (INT), established in 1928, stands as a center of excellence for pre-clinical, translational and clinical research activities, and clinical care. INT has 464 inpatient beds and provides more than 400.000 outpatient visits a year. The Institute carries out a public service characterized by a high level of diagnostic therapeutic and research activities. The inseparability, reciprocity and the functional continuum between clinic and research constitutes a constutional specificity, combined with the access to continuino care facilities qualifying INT as a Comprehensive Cancer Center, accrording to the criteria of the Organization of European Cancer Institutes (OECI).
The Institute has programs and projects in every field and phase of research, preclinical, epidemiological, public health and clinical. INT is the Italian coordinator of numerous national and international clinical trials also with early phase studies. Numerous clinical trials have characterized the Institute, where many milestones have been laid in the history of oncology and, even today, different therapy schemes and intervention techniques remain the only valid options for the treatment of gaps in tumors. In more recent years, the INT has been the first in Italy to conduct research on the biological and molecular characterization of tumors, which led to the identification of oncogenes at the origin of thyroid cancer and new biomarkers. The Institute also deals with training and personnel training, with educational activities formalized through agreements with universities, hosting numerous university specialists.
The center is totally dedicated to the cure of cancer and is divided into different departments that come together in: medical oncology, hematology, surgery, radiotherapy Within these departments there are highly specialized units following these tumours:
- Head and Neck
- Lymphoma and Myeloma
- Melanoma and Skin
- Pediatric tumours
The centre also has a number of specialised clinical services, including:
- Adolescent and Young Adult Oncology Programme
- Genetic consult
- Pain Clinic
- Prostate Programme
- Palliative Care Programme
Palliative and Supportive Care
The mission of Palliative Care, Pain Therapy and Rehabilitation Unit is to address the needs of patients in all stages of the disease with the aim of improving quality of life and provide a system of care and support fully integrated with the overall program of cancer diagnosis, therapy and research. Palliative care Unit provides: outpatients visits and day hospital, admission to hospice for frail patients with a particular focus on end of life care, consult service within the Institute and home care program for patients who wish spend the last periods of their life at home. Cancer Rehabilitation provides interventions that are appropriate for the recovery of acute and chronic consequences of surgery, radiation-therapy, and medical treatments as well as to support the complications of advanced cancer. The Unit is integrated with the palliative care team activities in the hospice and home care setting with specific organization modalities.